Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort.

ABSTRACT:

Background

Unruptured intracranial aneurysm treatment aims to reduce the risk of aneurysm rupture and bleeding, relieves symptoms and improve the quality of life for patients. This study aimed to assess the safety and efficacy of Pipeline Embolization Device (PED, Covidien/Medtronic, Irvine, CA) treatment for intracranial aneurysms presenting with mass effect in real-world settings.

Methods

We selected patients from the PED in China Post-Market Multi-Center Registry Study with mass effect presentation. The study endpoints included postoperative mass effect deterioration and mass effect relief at follow-up (3-36 months). We conducted multivariate analysis to identify factors associated with mass effect relief. Subgroup analyses by aneurysm location, size and form were also pe

SUBMITTER: Zhao Y 

PROVIDER: S-EPMC10956105 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature